Pay-on-detection cardiac screening
Find silent cardiac risk before it becomes a costly event.
The first platform purpose-built to screen populations for silent cardiac risk—and convert every detection into prevention, billing, and action.
Illustrative modeled scenario. Partner-specific assumptions, realization, and clinical pathways determine actual results.
The problem
Risk is not absent. It is undiscovered.
Population selection, monitoring access, clinical review, and follow-up often sit in separate systems. MbeleMed connects those steps so organizations can find more of the right people and act through governed clinical pathways—at home, in clinics, and through mobile and community settings.
Find the right population
AI-informed risk stratification prioritizes people most likely to benefit from screening.
Reach beyond specialty care
Device-agnostic workflows extend access while preserving local clinical authority.
Convert findings into action
Structured, CMS-compliant reports enable billing, outreach, follow-up, and measurement.
The operating layer
One pathway from population signal to accountable evidence.
Every stage names who acts. No clinical action proceeds without qualified physician review.
Prioritize
Apply approved risk criteria to identify who may benefit.
Reach
Meet people at home, in clinics, and through mobile or community settings.
Monitor
Use device-agnostic workflows for continuous cardiac monitoring.
Physician review
Qualified interpretation gates every clinical action.
Act
Document outreach, escalation, billing, and follow-up.
Measure
Record what was found, what was done, and what the program produced.
Commercial logic
Pay when actionable risk is confirmed.
MbeleMed’s fee can be tied to physician-confirmed actionable detections. Device cost, professional interpretation, downstream care, and partner-specific economics remain visible and separate.
Performance fee
Tied to physician-confirmed actionable detections.
Device and service
Diagnostic hardware and monitoring service.
Interpretation
Professional interpretation under the applicable pathway.
Follow-up
Care decisions, downstream services, and program evaluation.
Governance
Eligibility, clinical authority, evidence, and audit expectations.
Who wins
Built for organizations responsible for population outcomes.
Find preventable risk earlier.
Prioritize high-risk members, coordinate access, document follow-up, and evaluate program-specific economics.
Extend reach without surrendering authority.
Screen beyond specialty access while preserving physician interpretation and local clinical pathways.
Meet people where they are.
Bring governed cardiac-risk workflows closer to rural, underserved, and difficult-to-reach populations.
Evidence & credibility
Built to earn trust before scale.
Claims are labeled by evidence level so partners can distinguish published literature, modeled economics, demonstrated workflow, and pilot-stage work.
Detect. Prevent. Thrive.
We screen for what others miss—before it becomes a stroke, a cost, or a crisis.
Define the population, clinical authority, deployment pathway, and evidence your first program must produce.